Patents by Inventor Nazarius Saah Lamango

Nazarius Saah Lamango has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer Diagnosis by Measuring Polyisoprenylated Methylated Protein Methyl Esterase Activity
    Publication number: 20150167050
    Abstract: Methods for cancer diagnosis, making decisions on appropriate cancer treatment, awareness of a predisposition to cancer and potential cancer prevention, and monitoring of cancer therapy by measuring the activity of PMPMEase.
    Type: Application
    Filed: December 13, 2013
    Publication date: June 18, 2015
    Applicant: Florida Agricultural and Mechanical University
    Inventor: Nazarius Saah Lamango
  • Cancer diagnosis by measuring polyisoprenylated methylated protein methyl esterase activity
    Patent number: 8592173
    Abstract: Methods for cancer diagnosis, making decisions on appropriate cancer treatment, awareness of a predisposition to cancer and potential cancer prevention, and monitoring of cancer therapy by measuring the activity of PMPMEase.
    Type: Grant
    Filed: November 7, 2011
    Date of Patent: November 26, 2013
    Assignee: Florida Agricultural and Mechanical University
    Inventor: Nazarius Saah Lamango
  • Cancer Diagnosis by Measuring Polyisoprenylated Methylated Protein Methyl Esterase Activity
    Publication number: 20130084573
    Abstract: Methods for cancer diagnosis, making decisions on appropriate cancer treatment, awareness of a predisposition to cancer and potential cancer prevention, and monitoring of cancer therapy by measuring the activity of PMPMEase.
    Type: Application
    Filed: November 7, 2011
    Publication date: April 4, 2013
    Inventor: Nazarius Saah Lamango
  • Cancer diagnosis by measuring polyisoprenylated methylated protein methyl esterase activity
    Patent number: 8053207
    Abstract: Methods for cancer diagnosis and treatment; in particular, methods for diagnosis and treatment of triple negative breast cancer by measuring the activity of PMPMEase.
    Type: Grant
    Filed: January 25, 2011
    Date of Patent: November 8, 2011
    Assignee: Florida Agrlcultural and Mechanical University
    Inventor: Nazarius Saah Lamango
  • Inhibitors of polyisoprenylated methylated protein methyl esterase
    Patent number: 7897604
    Abstract: Inhibitors of the enzyme prenylated methylated protein methyl esterase (PMPMEase), the last step in the prenylation process for many eukaryotic proteins, having the general structure R1-X-A-B(R2)-Y or R1-X-A(R2)-B-Y, where R1 is preferably a polyisoprenyl group, X is a linking group, Y is a group that promotes affinity interactions to the active site of PMPMEase and imparts hydrolysis resistance to the inhibitor, A and B are bridge atoms, and R2 is a characteristic-providing substituent.
    Type: Grant
    Filed: April 7, 2008
    Date of Patent: March 1, 2011
    Assignee: Florida Agricultural and Mechanical University
    Inventor: Nazarius Saah Lamango
  • INHIBITORS OF POLYISOPRENYLATED METHYLATED PROTEIN METHYL ESTERASE
    Publication number: 20090253640
    Abstract: Inhibitors of the enzyme prenylated methylated protein methyl esterase (PMPMEase), the last step in the prenylation process for many eukaryotic proteins, having the general structure R1-X-A-B(R2)-Y or R1-X-A(R2)-B-Y, where R1 is preferably a polyisoprenyl group, X is a linking group, Y is a group that promotes affinity interactions to the active site of PMPMEase and imparts hydrolysis resistance to the inhibitor, A and B are bridge atoms, and R2 is a characteristic-providing substituent.
    Type: Application
    Filed: April 7, 2008
    Publication date: October 8, 2009
    Inventor: Nazarius Saah Lamango